[慢性炎症性脱细林性多神经病的治疗策略]
1Department of Neurology, Dokkyo Medical University.
Brain and nerve = Shinkei kenkyu no shinpo
|December 26, 2024
概括
慢性炎症性脱髓化多神经病 (CIDP) 的有效管理需要考虑诱导和维持疗法. 治疗方案包括血交换,免疫球蛋白疗法和皮质类固醇,通常在组合中使用.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性炎症性脱髓化多神经病 (CIDP) 是一种罕见的自身免疫性疾病,影响周围神经.
- 有效的管理策略对于改善患者的治疗结果和生活质量至关重要.
- 目前的治疗模式需要采取全面的方法,解决急性和长期疾病阶段.
研究的目的:
- 概述慢性炎症性脱髓化多神经病 (CIDP) 的主要治疗方法.
- 强调CIDP管理中不同的诱导和维持治疗策略的重要性.
- 审查各种治疗方案的疗效,包括免疫调节和免疫抑制疗法.
主要方法:
- 对CIDP的既定和新兴治疗方法的审查.
- 对疾病诱导和长期维持的治疗方法的分析.
- 为全面的患者管理考虑组合疗法.
主要成果:
- 血交换和静脉注射免疫球蛋白 (IVIg) 是CIDP的有效诱导治疗方法.
- 皮质类固醇在CIDP的诱导和维持阶段都显示出有效性.
- 重复的IVIg或皮下免疫球蛋白输注是可行的维持治疗选择.
结论:
- 整合诱导和维持疗法的定制方法对于最佳的CIDP管理至关重要.
- 使用血交换,免疫球蛋白治疗和皮质类固醇的组合策略提供了灵活的治疗选择.
- 目前正在进行的研究和临床实践应专注于针对CIDP患者的个性化治疗计划.
相关概念视频
Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
98
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
98
Myasthenia Gravis: Overview and Treatment
934
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
934
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Chronic Pancreatitis II: Collaborative Care
46
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
46


